A method for synthesizing antibody-coupled degradation agent dipeptide linkers

A seven-step synthetic route was developed using inexpensive and readily available p-aminobenzyl alcohol as a starting material, which solved the problems of low yield and complex purification in existing synthetic routes, and achieved efficient and low-cost preparation of the target product, suitable for large-scale production.

CN122079809APending Publication Date: 2026-05-26WUHAN AOFEI TECH CO LTD

Patent Information

Authority / Receiving Office
CN ยท China
Patent Type
Applications(China)
Current Assignee / Owner
WUHAN AOFEI TECH CO LTD
Filing Date
2024-11-25
Publication Date
2026-05-26

AI Technical Summary

Technical Problem

The existing synthetic routes for preparing ethyl 1-[(3S)-3-{[(4-{[(2-bromophenyl)oxy]methyl}phenyl)amino]carbonyl}-8-methyl-1-oxoylide-2,8-diazanon-1-yl]cyclobutane-1-carboxylate have problems such as low yield in the third-step condensation reaction and the need for two reverse-phase purifications, which makes it difficult to meet the growing market demand.

Method used

Using readily available and inexpensive commercial raw material p-aminobenzyl alcohol as the starting material, a novel synthetic route was developed through seven conventional reactions. Each of the seven steps requires no further purification and can be directly used in the next step. The target product was successfully prepared using inexpensive and readily available reagents and mild reaction conditions.

Benefits of technology

A high-purity, high-yield preparation of ethyl 1-[(3S)-3-{[(4-{[(2-bromophenyl)oxy]methyl}phenyl)amino]carbonyl}-8-methyl-1-oxonyl-2,8-diazanon-1-yl]cyclobutane-1-carboxylate was achieved, simplifying the operation process, reducing costs, and making it suitable for large-scale production at the hundred-gram level.

โœฆ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122079809A_ABST
    Figure CN122079809A_ABST
Patent Text Reader

Abstract

This invention discloses a method for synthesizing a dipeptide linker for antibody-coupled degradation, relating to the field of organic synthesis. 1-[(3S)-3-{[(4-{[(2-bromophenyl)oxy]methyl}phenyl)amino]carbonyl}-8-methyl-1-oxoylide-2,8-diazanon-1-yl]cyclobutane-1-carboxylic acid ethyl ester (CAS: 2760139-12-4) is a cleavable dipeptide linker for antibody-coupled degradation, which can be used to synthesize antibody-coupled active molecules. This invention uses readily available and inexpensive commercial raw material p-aminobenzyl alcohol as a starting material, and through seven conventional steps, obtains the target product with high purity and high yield. The starting material is inexpensive, the operation is simple, the reaction conditions are mild, and it can be prepared in large quantities at the hundred-gram scale, representing a completely new synthetic route.
Need to check novelty before this filing date? Find Prior Art